✦ LIBER ✦

A Clinical Screening Cooperative Group phase II evaluation of lobaplatin (ASTA D-19466) in advanced head and neck cancer

✍ Scribed by Marian Degardin; Jean Pierre Armand; Bernard Chevallier; Paul Cappelaere; Marie-Ange Lentz; Marc David; Henri Roché

Book ID: 104986027
Publisher: Springer US
Year: 1995
Tongue: English
Weight: 191 KB
Volume: 13
Category: Article
ISSN: 0167-6997
DOI: 10.1007/bf00873809

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Ifosfamide in advanced head and neck can

Ifosfamide in advanced head and neck cancer. A phase II study of the Rotterdam cooperative head and neck cancer study group

✍ Verweij, J.; Alexieva-Figusch, J.; De Boer, M.F.; Reichgelt, B.; Stoter, G. 📂 Article 📅 1988 🏛 Elsevier Science ⚖ 104 KB

Phase II study of cystemustine in advanc

Phase II study of cystemustine in advanced head and neck cancer. A trial of the EORTC clinical screening group

✍ P. Cappelaere; M.A. Lentz; M. Degardin; J. Chauvergne; F. Mayer; Ph. Chollet; B. 📂 Article 📅 1995 🏛 Elsevier Science 🌐 English ⚖ 163 KB

Phase II evaluation of galactitol in hea

Phase II evaluation of galactitol in head and neck cancer: A southwest oncology group study

✍ Haas, Charles D. ;Lehane, Daniel ;Bottomley, Richard 📂 Article 📅 1983 🏛 John Wiley and Sons 🌐 English ⚖ 208 KB

## Abstract A phase II evaluation of DAG in head and neck cancer patients produced one partial response and one patient with prolonged stable disease from nine fully evaluable patients with squamous carcinomas. One partial response was produced in a patient with anaplastic thyroid carcinoma. No dru

Final report of a phase II evaluation of

Final report of a phase II evaluation of paclitaxel in patients with advanced squamous cell carcinoma of the head and neck : An Eastern Cooperative Oncology Group trial (PA390)

✍ Arlene A. Forastiere; Darleen Shank; Donna Neuberg; Samuel G. Taylor IV; Ronald 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 68 KB 👁 2 views

The contents of this article are solely the responsibility of the authors and do not necessarily represent the official views of the National Cancer Institute.

Multicenter Randomized Phase II Clinical

Multicenter Randomized Phase II Clinical Trial of a Recombinant Human Endostatin Adenovirus in Patients with Advanced Head and Neck Carcinoma

✍ Ye, Wen; Liu, Ranyi; Pan, Changchuan; Jiang, Wenqi; Zhang, Li; Guan, Zhongzhen; 📂 Article 📅 2014 🏛 Nature Publishing Group 🌐 English ⚖ 909 KB

8513 POSTER DISCUSSION A Phase II Study

8513 POSTER DISCUSSION A Phase II Study of Neoadjuvant Bio-chemotherapy With Cetuximab, Paclitaxel, and Cisplatin (CPC) Followed by Cetuximab-based Concurrent Bio-radiotherapy in High-risk Locally Advanced Head and Neck Cancer – Representative of Head and Neck Cancer Study Group of Taiwan Cooperative Oncology Group

✍ Chang, K.Y.; Yen, C.J.; Hsieh, C.Y.; Tsou, H.H.; Chiu, C.F.; Chen, C.C.; Tsao, C 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 59 KB